Letters to the Editor

Inhibition of SUV39H1 as a potent therapeutic target in multiple myeloma

Institut de Génétique Humaine, Univ Montpellier, CNRS, Montpellier
Institut de Génétique Humaine, Univ Montpellier, CNRS, Montpellier, France; Department of Biological Hematology, CHU Montpellier, Montpellier
Institut de Génétique Humaine, Univ Montpellier, CNRS, Montpellier
Institut de Génétique Humaine, Univ Montpellier, CNRS, Montpellier
Helomnix, Montpellier
Institut de Génétique Humaine, Univ Montpellier, CNRS, Montpellier
Department of Biological Hematology, CHU Montpellier, Montpellier
Department of Biological Hematology, CHU Montpellier, Montpellier
CHU Montpellier, Department of Clinical Hematology, Montpellier
CHU Montpellier, Department of Clinical Hematology, Montpellier, France; UFR Médecine, Univ Montpellier, Montpellier
Institut de Génétique Humaine, Univ Montpellier, CNRS, Montpellier
Institut de Génétique Humaine, Univ Montpellier, CNRS, Montpellier, France; CHU Montpellier, Department of Clinical Hematology, Montpellier, France; UFR Médecine, Univ Montpellier, Montpellier
Institut de Génétique Humaine, Univ Montpellier, CNRS, Montpellier
Institut de Génétique Humaine, Univ Montpellier, CNRS, Montpellier, France; Department of Biological Hematology, CHU Montpellier, Montpellier, France; UFR Médecine, Univ Montpellier, Montpellier, France; Institut Universitaire de France (IUF), Paris
Institut de Génétique Humaine, Univ Montpellier, CNRS, Montpellier, France; Department of Biological Hematology, CHU Montpellier, Montpellier, France; UFR Médecine, Univ Montpellier, Montpellier
Haematologica Early view Apr 16, 2026 https://doi.org/10.3324/haematol.2025.300333